Accomplished healthcare executive brings extensive drug development and regulatory experience from global pharmaceutical companies to Marker Therapeutics.
Los Angeles-based biotechnology company Appia Bio said this morning that it has named Robert S. Negrin, M.D., to its Scientific Advisory Board. Dr. Negrin is a professor of medicine and former chief of th